Patent ID: 8129122
Filing Date: 2012-03-06
Classification: C12Q,G01N

Abstract:
1. A method for predicting metastasis of an oral cavity cancer to a cervical lymph node, the method comprising: assaying expression amounts of a metastasis prediction gene group in which the expression amounts are changed between a metastasis group indicating that the oral cavity cancer metastasizes to the cervical lymph node and a non-metastasis group indicating that the oral cavity cancer does not metastasize to the cervical lymph node, based on a sample collected from a primary lesion of the oral cavity cancer; predicting a probability that the oral cavity cancer metastasizes to the cervical lymph node by comparing the expression amounts of the metastasis prediction gene group with the expression amounts of metastasis prediction genes in the metastasis group and/or the non-metastasis group; wherein the metastasis prediction gene group includes 2 genes: MSR1 (NM